W. MacNee (Edinburgh, United Kingdom), M. Kneussl (Vienna, Austria)
Fibrotic component in patients with emphysema reduces both exercise capacity and quality of life and increases exacerbations
N. Kokuho, T. Ishii, H. Hayashi, M. Kurahara, T. Motegi, K. Hattori, K. Yamada, K. Kamio, A. Gemma, K. Kida (Tokyo, Japan)
|   |
Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD
B. Nuñez, J. Sauleda, J. M. Antó, M. R. Julià, E. Barreiro, E. Monsó, A. Noguera, J. Gea, F. Gómez, J. Garcia-Aymerich, A. Agustí, PAC-COPD Investigators (Palma de Mallorca, Bunyola, Barcelona, Badalona, Spain)
| |
Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease
P. Joppa, J. Ukropec, P. Skyba, B. Ukropcova, P. Pobeha, K. Stroffekova, M. Brusik, D. Gasperikova, R. Tkacova (Kosice, Bratislava, Slovakia)
| |
Anemia predicts mortality after COPD exacerbation
A. Munoz Ferrer, C. Martínez, K. Portillo, P. Serra, M. L. Martínez, I. Garcia Olivé, M. Prats, J. Ruiz Manzano, J. Morera (Badalona, Spain)
| |
Relation of cardiac enzymes and echocardiographical findings with long-term mortality after chronic obstructive pulmonary disease exacerbation
E. C. Seyhan, N. Veske, G. Günlüoglu, S. Sökücü, M. Düger, S. Altin (Istanbul, Turkey)
| |
Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease
P. Pobeha, J. Ukropec, P. Joppa, B. Ukropcova, P. Skyba, M. Javorsky, D. Gasperikova, R. Tkacova (Kosice, Bratislava, Slovakia)
| |
Reduced grip strength is related to frequency of exacerbations and lower health status in COPD
K. Ansari, J. Munby, G. Burn, I. Taylor, A. Kay, M. Farrow, N. Keaney (Sunderland, Newcastle upon Tyne, United Kingdom)
| |
Gender differences in formation of endothelial dysfunction (ED) extension in COPD patients
L. Konopkina, T. Pertseva (Dnipropetrovsk, Ukraine)
| |
COPD GOLD stage 1: Is it really a disease?
J. Bourbeau, W. Tan, R. Cowie, P. Hernandez, K. Chapman, A. Benedetti, P. Mancino, M. F. Sedeno, P. Z. Li, S. Ling, L. Zheng, S. Bernard, For CanCOLD Study Group (Montreal, Vancouver, Calgary, Halifax, Toronto, Quebec, Canada)
| |
Anemia in chronic respiratory failure
F. Kollert, C. Müller, A. Tippelt, R. A. Joerres, D. Heidinger, C. Probst, M. Pfeifer, S. Budweiser (Freiburg, Donaustauf, Munich, Regensburg, Rosenheim, Germany)
| |
Association of inflammation and bronchial hyperresponsiveness
I. Trofimenko, B. Chernyak (Irkutsk, Russian Federation)
| |
Body mass index, central obesity, and severity of chronic obstructive pulmonary disease (COPD)
Z. Stojanovski, J. Minov, J. Bojan, I. Sasa (Skopje, Kumanovo, Fyrom)
| |
The expression of brain-derived neurotrophic factor in hippcocampal and serum of chronic obstructive pulmonary disease model rats
Q. Wang, Y. Lin, X. Ling, S. Sun, Q. Zhang (Nanjing, China)
| |
Changes in arterial stiffness during COPD exacerbations
A. R. C. Patel, A. J. Mackay, B. Kowlessar, G. C. Donaldson, J. A. Wedzicha, J. R. Hurst (London, United Kingdom)
| |
Total serum bilirubin levels are not related to the severity of COPD
F. M. E. Franssen, M. A. Spruit, L. G. M. Fransen, E. F. M. Wouters (Horn, Netherlands)
| |
Arterial stiffness measurements in COPD: Reliability over time
A. R. C. Patel, A. J. Mackay, B. Kowlessar, G. C. Donaldson, J. A. Wedzicha, J. R. Hurst (London, United Kingdom)
| |
Evaluation of upper airway involvement and interleukin-8 levels in nasal lavage fluid of stable COPD patients
H. Çelik, S. Akpinar, B. Dursun, P. Oktar, H. Karabulut, T. Sipit (Ankara, Turkey)
| |